Form 4: Hims & Hers Health CFO Oluyemi Okupe Executes Stock Option and Sells Shares
SEC Form 4 Filing
Oluyemi Okupe, CFO of Hims & Hers Health, exercised stock options and sold shares of Class A Common Stock on March 4, 2024, according to a Form 4 filing with the SEC.
Summary
- On March 4, 2024, Oluyemi Okupe, the Chief Financial Officer of Hims & Hers Health, Inc. (HIMS), exercised stock options to acquire 40,527 shares of Class A Common Stock at a price of $5.01 per share.
- Okupe then sold a total of 50,574 shares of Class A Common Stock in multiple transactions at weighted average prices ranging from $13.4038 to $13.5723.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on May 10, 2023.
- Following these transactions, Okupe beneficially owns 146,674 shares of Class A Common Stock and 964,395 stock options.
Sentiment
Score: 5
Explanation: The sentiment is neutral as it simply reports transactions. The use of a 10b5-1 plan suggests pre-planned sales, not necessarily a negative outlook, but the sales themselves could be interpreted in various ways.
Industry Context
Form 4 filings are routine disclosures required by the SEC when corporate insiders, like the CFO, trade their company's stock. These filings are closely watched by investors for insights into management's perspective on the company's value and future prospects.
Comparison to Industry Standards
- Monitoring insider transactions is a common practice in financial analysis.
- Comparing Okupe's transactions to those of CFOs at similar telehealth companies (e.g., Teladoc, Amwell) could provide context.
- Analyzing the timing and size of these transactions relative to Hims & Hers' financial performance and stock price trends is important.
- The use of a 10b5-1 trading plan is a standard practice to avoid accusations of insider trading.
Stakeholder Impact
- Shareholders may interpret the stock sales as a lack of confidence, although the pre-planned nature of the trades mitigates this concern.
- The transactions have no immediate impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 2022-01-24 | Vesting Commencement Date |
| 2023-05-10 | Date of adoption of Rule 10b5-1 trading plan |
| 2024-03-04 | Date of stock option exercise and stock sales |
| 2024-03-05 | Date of signature on the Form 4 |
| 2032-02-23 | Expiration date of stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.